Latest News

  • Novel Biomarker Tracks Tightly With Tau Tangles In Alzheimer’s Disease

    Diagnostics World | Researchers in the U.S. and Sweden have identified a biomarker (MTBR-tau243) for Alzheimer’s disease that tracks with the amount of damaging tau tangles in the brain and, when combined with a specific phosphorylated tau species (p-tau205), is nearly as predictive of cognitive function as tau-positron emission tomography (tau-PET) imaging.

    Sep 19, 2023
  • Emerging Tools Aim to Reduce Stroke-Related Deaths and Disabilities

    Diagnostics World | Researchers from Johns Hopkins University and the Risk Management Foundation of the Harvard Medical Institutions have come up with a national estimate of serious harms from diagnostic error.

    Sep 13, 2023
  • Study Finds Breast Cancer Spreads During Sleep, Highlights Role Of Hormones

    Diagnostics World | The recent discovery that the metastatic spread of breast cancer accelerates during sleep sparked a lively conversation at last month’s Next Generation Dx Summit about new paths of exploration for thwarting a deadly pan-cancer process claiming 12 lives worldwide every minute.

    Sep 12, 2023
  • Neurosurgeons In Czech Republic Test Writing Capabilities Of ChatGPT

    Diagnostics World | Researchers in the Czech Republic succeeded in using ChatGPT (Chat Generative Pre-trained Transformer) to produce a convincing scientific article in only one hour with no special human training—a feat intended to point out the current capabilities of large language models (LLMs).

    Sep 7, 2023
  • Illumina Names Jacob Thaysen of Agilent New CEO

    Diagnostics World News | Illumina today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., senior vice president of Agilent Technologies and president of its Life Sciences and Applied Markets Group, as Illumina’s next Chief Executive Officer, effective September 25, 2023.

    Sep 5, 2023